Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Non-Current Deffered Revenue (2020 - 2021)

Historic Non-Current Deffered Revenue for Terns Pharmaceuticals (TERN) over the last 2 years, with Q4 2021 value amounting to $160000.0.

  • Terns Pharmaceuticals' Non-Current Deffered Revenue fell 2727.27% to $160000.0 in Q4 2021 from the same period last year, while for Dec 2021 it was $160000.0, marking a year-over-year decrease of 2727.27%. This contributed to the annual value of $160000.0 for FY2021, which is 2727.27% down from last year.
  • As of Q4 2021, Terns Pharmaceuticals' Non-Current Deffered Revenue stood at $160000.0, which was down 2727.27% from $176000.0 recorded in Q3 2021.
  • In the past 5 years, Terns Pharmaceuticals' Non-Current Deffered Revenue registered a high of $220000.0 during Q4 2020, and its lowest value of $160000.0 during Q4 2021.